Literature DB >> 2121567

Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation.

P C Butler1, E J Kryshak, M Marsh, R A Rizza.   

Abstract

Insulin-stimulated glucose oxidation is decreased in patients with non-insulin-dependent diabetes mellitus (NIDDM). It is not known whether this decrease is due to a primary defect in the oxidative pathway or is secondary to impaired glucose transport and/or phosphorylation. To address this issue, glucose oxidation was measured under steady-state conditions at low (approximately 270 pmol) and high (approximately 17 mumol) insulin concentrations in seven patients with NIDDM and seven healthy nondiabetic subjects matched for sex, age, and obesity. Glucose oxidation was measured simultaneously by indirect calorimetry and the isotopedilution technique. Although glucose oxidation and nonoxidative storage were lower (P less than 0.05) in diabetic than nondiabetic subjects during the low- and high-dose insulin infusions, oxidation of intracellularly derived glucose, estimated by subtracting the rate of oxidation measured isotopically (i.e., glucose oxidation derived from the extracellular space) from that measured by indirect calorimetry (i.e., total glucose oxidation), did not differ in diabetic and nondiabetic subjects during the low-dose insulin infusion (3.3 +/- 0.1 vs. 3.0 +/- 0.1 mumol.kg-1.min-1). Both techniques provided identical estimates of glucose oxidation during the high-dose insulin infusion. Impaired oxidation of extracellularly but not intracellularly derived glucose strongly suggests that the cause of decreased glucose oxidation in patients with NIDDM is secondary to impaired glucose transport and/or phosphorylation rather than a primary abnormality in the oxidative pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121567     DOI: 10.2337/diab.39.11.1373

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 2.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

3.  Variant sequences of the Hexokinase II gene in familial NIDDM.

Authors:  R W Taylor; R L Printz; M Armstrong; D K Granner; K G Alberti; D M Turnbull; M Walker
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

4.  The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.

Authors:  D E Kelley; M A Mintun; S C Watkins; J A Simoneau; F Jadali; A Fredrickson; J Beattie; R Thériault
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population.

Authors:  W H Lin; L M Chuang; C H Chen; J I Yeh; P S Hsieh; C H Cheng; Y T Chen
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

6.  Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Authors:  A Vaag; F Alford; F L Henriksen; M Christopher; H Beck-Nielsen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

7.  Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  S Del Prato; R C Bonadonna; E Bonora; G Gulli; A Solini; M Shank; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance.

Authors:  W T Garvey; L Maianu; J H Zhu; G Brechtel-Hook; P Wallace; A D Baron
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production.

Authors:  L Rossetti; M Hu
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

10.  Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  M G Baroni; R S Oelbaum; P Pozzilli; J Stocks; S R Li; V Fiore; D J Galton
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.